Maureen Ibanez

1.5k total citations
15 papers, 413 citations indexed

About

Maureen Ibanez is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Maureen Ibanez has authored 15 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Surgery. Recurrent topics in Maureen Ibanez's work include Osteoarthritis Treatment and Mechanisms (3 papers), Knee injuries and reconstruction techniques (2 papers) and Tendon Structure and Treatment (2 papers). Maureen Ibanez is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (3 papers), Knee injuries and reconstruction techniques (2 papers) and Tendon Structure and Treatment (2 papers). Maureen Ibanez collaborates with scholars based in United States, Netherlands and Switzerland. Maureen Ibanez's co-authors include V. Deshmukh, Yusuf Yazıcı, T. Seo, John Hood, Joshua D. Stewart, Luis Dellamary, Kevin Chiu, J. Tambiah, Charlene F. Barroga and S. KC and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Infection and Immunity.

In The Last Decade

Maureen Ibanez

13 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Ibanez United States 7 178 138 61 53 46 15 413
Shutao Xie United States 11 248 1.4× 61 0.4× 68 1.1× 58 1.1× 12 0.3× 12 592
Toshiharu Fujiyama Japan 15 75 0.4× 107 0.8× 40 0.7× 78 1.5× 13 0.3× 42 733
Yoon‐Joong Kang South Korea 11 154 0.9× 34 0.2× 18 0.3× 46 0.9× 120 2.6× 24 543
S. Kleinboelting Germany 8 199 1.1× 61 0.4× 16 0.3× 17 0.3× 32 0.7× 11 435
Kouichi Miyazawa Japan 5 330 1.9× 14 0.1× 26 0.4× 32 0.6× 45 1.0× 7 799
Yu-Hsuan Chen Taiwan 8 387 2.2× 26 0.2× 18 0.3× 45 0.8× 30 0.7× 13 639
Corinne Petit-Frère United Kingdom 13 277 1.6× 31 0.2× 12 0.2× 100 1.9× 15 0.3× 20 645
Simon Girel France 3 105 0.6× 22 0.2× 9 0.1× 49 0.9× 24 0.5× 4 358
David Lemus Chile 10 182 1.0× 7 0.1× 43 0.7× 45 0.8× 122 2.7× 23 442
Maja Matulić Croatia 10 187 1.1× 11 0.1× 12 0.2× 68 1.3× 22 0.5× 31 407

Countries citing papers authored by Maureen Ibanez

Since Specialization
Citations

This map shows the geographic impact of Maureen Ibanez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Ibanez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Ibanez more than expected).

Fields of papers citing papers by Maureen Ibanez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Ibanez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Ibanez. The network helps show where Maureen Ibanez may publish in the future.

Co-authorship network of co-authors of Maureen Ibanez

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Ibanez. A scholar is included among the top collaborators of Maureen Ibanez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Ibanez. Maureen Ibanez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Murphy, Eric A., et al.. (2024). Abstract LB173: Discovery of ALTA-2618, the first allosteric, mutant-selective targeted therapy for AKT1 E17K driven cancers. Cancer Research. 84(7_Supplement). LB173–LB173. 1 indexed citations
2.
Jarvis, Matthew C., Gopi Kumar Mittapalli, Chelsea Nora, et al.. (2023). Abstract 5019: Next-generation DYRK1A inhibitors as a new therapeutic approach for the treatment of hematological malignancies. Cancer Research. 83(7_Supplement). 5019–5019. 1 indexed citations
3.
McMillan, Elizabeth A., Carine Bossard, Carsten Merkwirth, et al.. (2022). Abstract 3928: The pan-CLK/DYRK inhibitor cirtuvivint selectively disrupts alternative splicing and has broad anti-tumor activity in preclinical models. Cancer Research. 82(12_Supplement). 3928–3928.
4.
Deshmukh, V., Maureen Ibanez, Ying Wei, et al.. (2020). A small-molecule inhibitor of the Wnt pathway, lorecivivint (SM04690), as a potential disease-modifying agent for the treatment of degenerative disc disease. The Spine Journal. 20(9). 1492–1502. 8 indexed citations
5.
Deshmukh, V., T. Seo, Maureen Ibanez, et al.. (2020). SM04755, a small‐molecule inhibitor of the Wnt pathway, as a potential topical treatment for tendinopathy. Journal of Orthopaedic Research®. 39(9). 2048–2061. 25 indexed citations
8.
Deshmukh, V., Charlene F. Barroga, Carine Bossard, et al.. (2017). A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage. 26(1). 18–27. 176 indexed citations
9.
Deshmukh, V., Charlene F. Barroga, Maureen Ibanez, et al.. (2017). Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis. Osteoarthritis and Cartilage. 25. S310–S311. 2 indexed citations
10.
Deshmukh, V., Charlene F. Barroga, Maureen Ibanez, et al.. (2017). SAT0549 Anti-inflammatory properties of SM04690, a small molecule inhibitor of the wnt pathway as a potential treatment for knee osteoarthritis. Annals of the Rheumatic Diseases. 76. 984–984. 1 indexed citations
11.
Swann, Justine, Victoria Corey, Christina Scherer, et al.. (2016). High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria. ACS Infectious Diseases. 2(4). 281–293. 55 indexed citations
12.
Chu, Daniel I., Richard D. Bungiro, Maureen Ibanez, et al.. (2004). Molecular Characterization ofAncylostoma ceylanicumKunitz-Type Serine Protease Inhibitor: Evidence for a Role in Hookworm-Associated Growth Delay. Infection and Immunity. 72(4). 2214–2221. 50 indexed citations
13.
Gruber, Andreas, David J. Looney, Maureen Ibanez, & Flossie Wong‐Staal. (2001). Altered immunophenotype of dendritic cells generated from HIV infected subjects. Immunology Letters. 78(3). 209–211. 1 indexed citations
14.
Pellacani, Andrea, Michael T. Chin, Philippe Wiesel, et al.. (1999). Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1β in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 274(3). 1525–1532. 36 indexed citations
15.
Perrella, Mark A., Andrea Pellacani, Philippe Wiesel, et al.. (1999). High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer. Journal of Biological Chemistry. 274(13). 9045–9052. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026